TX_NEW (version: 2.2)

Number of adults and children newly enrolled on antiretroviral therapy (ART)


Download MER Manual

Numerator

Number of adults and children newly enrolled on antiretroviral therapy (ART) and uptake of ART programs.

The indicator measures the ongoing scale-up

Changes to Indicator

  • TB disaggregate added to the indicator (MER 1.0 to MER 2.0).
  • Key population disaggregate added to the indicator (MER 1.0 to MER 2.0).
  • Age/sex disaggregates updated (MER 2.0 v2.1 to v2.2).
  • Clarifying language added for Key Populations disaggregation the notes that KP should be counted in only one KP group to avoid double-counting. More information is provided below (MER 2.0 v2.1 to v2.2).

How to Use

The indicator measures the ongoing scale-up and uptake of ART programs. This measure is critical to monitor along with number of patients currently on ART in relation to the number of PLHIV that are estimated to be eligible for treatment to assess progress in the program's response to the epidemic in specific geographic areas and populations as well as at the national level. This is particularly critical in the context of current revisions to country-specific ART eligibility.

Reporting the number of new patients enrolled on ART at both the national and overall PEPFAR program levels is critical to monitoring the HIV services cascade, specifically the successful linkage between HIV diagnosis and initiating ART. Disaggregation of new on ART by age/sex at ART initiation, pregnancy status at ART initiation, and breastfeeding status at ART initiation is important to understand the percentage of new ART initiations coming from priority populations.

How to Collect Data

Facility ART registers/databases, program monitoring tools, or drug supply management systems.

  • The numerator can be generated by counting the number of adults and children who are newly enrolled in ART in the reporting period, in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards).
  • Patients who known to transfer in from another facility, or who temporarily stopped therapy and have started again should not be counted as new patients.
  • NEW is a state defined by an individual initiating ART during the reporting period. It is expected that the characteristics of new clients are recorded at the time they newly initiate life-long ART. For example, patients who receive post-exposure prophylaxis (PEP), short term ART only for prevention (PREP), or ART starter pack alone should not be used to count individuals reached with this indicator.

TB/ HIV disaggregation: At initiation of ART, number of patients with a confirmed diagnosis of TB (new and relapsed) and/or on TB treatment collected from TB/HIV registers;

Pregnant/BF disaggregation: Women who initiate ART while breastfeeding should be counted under this indicator but not in PMTCT_ART. Women who initiate during pregnancy and are reported under PMTCT_ART should also be reported here.

Key population disaggregation* see Appendix 1 to support the identification of key populations at ART initiation. However, reporting of key population disaggregation should be consistent with what is described under the KP_PREV "How to review for data quality" section on mutual exclusivity of an individual who falls under multiple KP categories (e.g., FSW who injects drugs). In such instances, the individual should only be reported in ONE KP disaggregation category with which s/he is most identified in order to avoid double-counting.

NOTE: both KP-specific and clinical partners have the option to complete these disaggs, but only if safe to maintain these files and to report.

Reporting Level

Facility

Reporting Frequency

Quarterly

How to Review for Data Quality

data quality" section on mutual exclusivity of an individual who falls under multiple KP categories (e.g., FSW who injects drugs). In such instances, the individual should only be reported in ONE KP disaggregation category with which s/he is most identified in order to avoid double-counting.

NOTE: both KP-specific and clinical partners have the option to complete these disaggs, but only if safe to maintain these files and to report. Reporting level: Facility How often to report: Quarterly

How to Calculate the Annual Total

Sum across all reporting periods

Data Elements and Disaggregates

Numerator Disaggregate Groups Disaggregates
Number of adults and children newly enrolled on antiretroviral therapy (ART) Age/Sex [Required] <1, 1-9, 10-14 M, 10-14 F, 15-19 M, 15-19 F, 20-24 M, 20-24 F, 25-29 M, 25-29 F, 30-34 M, 30-34 F, 35-39 M, 35-39 F, 40-49 M, 40-49 F, 50+ M, 50+ F
TB/HIV Status [Required} Number new on treatment with confirmed diagnosis of TB (new and relapsed) and/or TB treated
Pregnancy and breastfeeding status at ART initiation [Required]
  • Pregnant at initiation of ART;
  • Breastfeeding at initiation of ART
Key Population Type [Optional]
  • People who inject drugs (PWID)
  • Men who have sex with men (MSM)
  • Transgender people (TG)
  • Female sex workers (FSW)
  • People in prison and other closed settings

Disaggregate Descriptions & Definitions

Age/Sex: Age is defined as the age of the patient at the date of initiation on ART, not the age at the date of reporting.

PEPFAR-Support Definition

Standard definition of DSD and TA-SDI used. Provision of key staff or commodities for PLHIV receiving ART include: the provision of key staff and/or commodities can include ongoing procurement of critical commodities, such as ARVs, or funding for salaries of HCW who deliver HIV treatment services. Staff who are responsible for the completeness and quality of routine patient records (paper or electronic) can be counted here; however, staff who exclusively fulfill MOH and donor reporting requirements cannot be counted. Ongoing support for PLHIV receiving ART service delivery improvement includes: clinical mentoring and supportive supervision of staff at HIV sites providing ART, support for quality improvement activities, patient tracking system support, routine support of ART M&E and reporting, commodities consumption forecasting and supply management.

Guiding Narrative Questions

  1. If TX_NEW does NOT equal HTS_TST_POS, explain why.
  2. If TX_NEW result is markedly different from targets, explain why.